SCHEMBL7964042

SCHEMBL7964042

Cc1cc(Cl)ccc1C1(O)CCN(CCCNNC(=O)NN)CC1

nearest known ligand 0.46

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 9/20 0.46
CCR1 P32246 9/20 0.43
DRD4 P21917 1/20 0.43
DRD3 P35462 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7961470 0.88 DRD2 (0.49) DRD2CCR1
SCHEMBL7964044 0.84 DRD2 (0.53) DRD2DRD4DRD3
SCHEMBL7960074 0.83 DRD2 (0.62) DRD2CCR1
SCHEMBL7957164 0.82 DRD2 (0.56) DRD2CCR1
SCHEMBL7961380 0.81 DRD2 (0.54) DRD2CCR1DRD4DRD3
SCHEMBL7949530 0.80 DRD2 (0.56) DRD2CCR1DRD4DRD3
SCHEMBL7960233 0.79 CCR1 (0.54) DRD2CCR1DRD4DRD3
SCHEMBL7949042 0.79 CCR1 (0.52) DRD2CCR1
SCHEMBL7957632 0.79 CCR2 (0.42) DRD2DRD4DRD3
SCHEMBL7959911 0.78 CCR1 (0.45) DRD2CCR1DRD4DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed